BioCardia Inc

General ticker "BCDA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $6.1M

BioCardia Inc does not follow the US Stock Market performance with the rate: -41.7%.

Estimated limits based on current volatility of 4.7%: low 1.88$, high 2.06$

Factors to consider:

  • Current price 49.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.01$, 13.38$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.02$, 8.99$]

Financial Metrics affecting the BCDA estimates:

  • Negative: Non-GAAP EPS, $ of -1.81 <= 0.10
  • Negative: Operating profit margin, % of -96.06 <= 1.03
  • Negative: Operating cash flow per share per price, % of -42.52 <= 2.35
  • Negative: negative Net income
  • Negative: -0.39 < Industry inventory ratio change (median), % of 0

Similar symbols

Short-term BCDA quotes

Long-term BCDA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.01MM $1.35MM $0.48MM
Operating Expenses $13.64MM $13.25MM $12.12MM
Operating Income $-12.63MM $-11.90MM $-11.64MM
Non-Operating Income $0.01MM $-0.01MM $0.07MM
Interest Expense $0.00MM $0.01MM $0.00MM
R&D Expense $8.56MM $8.83MM $7.73MM
Income(Loss) $-12.62MM $-11.91MM $-11.57MM
Profit(Loss) $-12.62MM $-11.91MM $-11.57MM
Stockholders Equity $10.38MM $4.89MM $-1.60MM
Inventory $0.00MM $0.20MM $0.00MM
Assets $15.72MM $9.79MM $2.99MM
Operating Cash Flow $-10.37MM $-10.56MM $-9.97MM
Capital expenditure $0.12MM $0.07MM $0.01MM
Investing Cash Flow $-0.12MM $-0.07MM $-0.01MM
Financing Cash Flow $1.95MM $5.12MM $3.73MM
Earnings Per Share* $-11.19 $-10.08 $-8.19

* EPS are Split Adjusted, recent splits may be reflected with a delay.